Search for Clinical Trial Results

Sponsored By

Lambert-Eaton Myasthenic Syndrome - 22 Studies Found

Status Study
No longer available Study Name: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Date: 2011-06-13
Interventions: Drug: 3,4 DAP Recommended maximum dosage: 20mg four times daily and if needed an additional 20 mg per da
Recruiting Study Name: Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)
Condition: Lambert-Eaton Myasthenic Syndrome
Date: 2016-11-16
Interventions:
  • Drug: Amifampridine Phosphate
  • Drug: Placeb
Completed Study Name: A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
Condition: Lambert Eaton Myasthenic Syndrome
Date: 2011-06-17
Interventions:
  • Drug: Amifampridine Phosphate

Available Study Name: Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
Condition: Lambert-Eaton Myasthenic Syndrome
Date: 2009-10-08
Interventions: Drug: 3,4 diaminopyridine 3,4 diaminopyridine up to 80 mg daily in divided doses
Available Study Name: Treatment of Lambert-Eaton Syndrome With 3,4 DAP
Condition: Lambert Eaton Myasthenic Syndrome
Date: 2008-06-23
Interventions: Drug: 3, 4 DAP Patients with clinically-confirmed LEMS will receive 3, 4 DAP by mouth in slowly increasi
No longer available Study Name: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
Condition: Lambert Eaton Myasthenic Syndrome (LEMS)
Date: 2011-06-20
Interventions: Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less.
No longer available Study Name: Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Condition:
Date: 2023-03-24
Recruiting Study Name: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)
Condition:
  • Lambert-Eaton Myasthenic Syndrome
  • Congenital
  • Drug: 3,4-DIAMINOPYRIDINE Trea
Available Study Name: Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
Condition: Lambert Eaton Myasthenic Syndrome
Date: 2013-03-22
Interventions: Drug: 3, 4-Diaminopyridine
Completed Study Name: Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Date: 2000-02-24
Interventions: Drug: 3,4-diaminopyridine
Next >>>